SANDOSTATIN LAR

This brand name is authorized in Australia, Cyprus, Estonia, Croatia, Ireland, Japan, Lithuania, Malta, Romania, Singapore, Turkey, United Kingdom, South Africa

Active ingredients

The drug SANDOSTATIN LAR contains one active pharmaceutical ingredient (API):

1 Octreotide UNII 75R0U2568I - OCTREOTIDE ACETATE

Octreotide is a synthetic octapeptide derivative of naturally occurring somatostatin with similar pharmacological effects, but with a considerably prolonged duration of action. It inhibits pathologically increased secretion of growth hormone (GH) and of peptides and serotonin produced within the GEP endocrine system. Read about Octreotide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SANDOSTATIN LAR Powder and solvent for suspension for injection	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
H01CB02	Octreotide	H Systemic hormonal preparations, excl. Sex hormones and insulins → H01 Pituitary and hypothalamic hormones and analogues → H01C Hypothalamic hormones → H01CB Somatostatin and analogues
Discover more medicines within H01CB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10533J, 10543X, 10549F, 10550G, 10558Q, 10566D, 11501H, 11512X, 11537F, 11893Y, 11894B, 11896D
Country: EE	Ravimiamet	Identifier(s): 1041309, 1041310, 1041321, 1875359, 1875371, 1875393
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 41506, 41536, 41539
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-791598560, HR-H-983646054
Country: IE	Health Products Regulatory Authority	Identifier(s): 88179, 88180, 88181
Country: JP	医薬品医療機器総合機構	Identifier(s): 2499403G1021, 2499403G2028, 2499403G3024
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1067019, 1067022, 1067024
Country: MT	Medicines Authority	Identifier(s): MA1249/00603, MA1249/00604, MA1249/00605
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W42954002, W42954003, W42955002, W42955003, W42956002, W42956003
Country: SG	Health Sciences Authority	Identifier(s): 11637P, 11638P, 11645P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699504770018, 8699504770056, 8699504770100
Country: ZA	Health Products Regulatory Authority	Identifier(s): 33/34/0239, 33/34/0240, 33/34/0241, 33/34/0242